Protons, Photons, & everything in between. Join us on July 15th as we breakdown NRG-GI003 comparing protons & photons for hepatocellular carcinoma with study PI, Dr. Ted Hong. Listen to older episodes and find where to follow at #LiverTwitter #LiverX #HCC

July FORTE Fridays! Important Amendment updates, next Coordinator Session & more! ↪️ @Fortestudy

We have recently updated our #NRG2025 agenda with room information for the in-person sessions in Washington, DC. Check it out -

Interview with @TedHong9 and co-hosts @StephenChunMD and @lauren_henke.

Interested in SOROCk & still have questions? There are many places to find answers! Follow the QR code on the post to the NRG study page, which includes an FAQ section and the Patient Study Brochure. As always, reach out to NRG and study site personnel with additional questions!

NRG Oncology Membership Reminders:

NRG Oncology Weekly Broadcast for July 7, 2025:

RT @CJTsaiMDPhD: 🚨📢🌟 CURB2 Ph3 Trial is activated by @NCICTEP_ClinRes (NCT06686771), built upon CURB Ph2 RCT @TheLancet/@MSKCancerCenter.….

Happy 4th of July! . All NRG locations are closed today in observance of the Independence Day holiday.

Our new NRG Oncology Sarcoma Subcommittee will focus on building a more robust sarcoma program in our research portfolio; serve as a resource for investigators & collaborate closely with the other NCTN groups to promote sarcoma research. Read more ➡️

All NRG Operations Offices, SDMCs and the Biospecimen Banks will be closed on Friday, July 4th in observance of the Independence Day holiday. 🎆.

July is Bone Cancer Awareness Month. We recently activated the NRG-CC014 PREEMPT study, enrolling patients with high-risk bone metastases that are asymptomatic. ↪️ Stay tuned for our podcast episode later this month with study PI, @ErinGillespieMD

Announcing the #NRG2025 Translational Science Committee session! Join co-chairs, Dr Birrer, @VeredStearns & @APDicker for this educational session to hear presentations on some of the latest translational projects going on within NRG Oncology. Details ⬇️

RT @fortestudy: The NRG Oncology FORTE team is excited to host the FORTE Coordinator Session with support from the FORTE Coordinator Commit….

Happy 4th of July from the SOROCk team! A critical aspect of ovarian cancer prevention in patients with BRCA1 mutations is genetic testing of family members, so that everyone knows their own risk. We encourage everyone to talk about genetic testing.

NRG-GY028 has met its accrual goal and is permanently closed to patient accrual as of July 1, 2025. Documents are posted on @TheCTSU.

RT @dsmgyo: Comparing #durvalumab, #olaparib, and #cediranib monotherapy, combination therapy, or #chemotherapy in patients with platinum-r….

NRG Oncology Weekly Broadcast for June 30, 2025:

We are pleased to announce the enrollment of the 100th and 101st patients to the HERO Study. Thank you to Northwest Cancer Center – Hobart and University of Vermont Medical Center for helping us reach this milestone! @UVMMedCenter @nwcancercenter

NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer: Future Oncology